Page 7 - 2019_11 Resto del Mondo-web

Acute Myeloid Leukemia
2215 Cell-intrinsic depletion of Aml1-ETO-expressing pre-leukemic hematopoietic stem cells by K-Ras activating mutation Cristina Di Genua et al.
2225 Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia
Xinyu Li et al.
Non-Hodgkin Lymphoma
2241 Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial
Riccardo Bruna et al.
Chronic Lymphocytic Leukemia
2249 High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance
José A. García-Marco et al.
2258 Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy
Anthony R. Mato et al.
Plasma Cell Disorders
2265 Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the carthadex trial
Ruth Wester et al.
2274 Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial Monique C. Minnema et al.
Platelet Biology & its Disorders
2283 Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia Michael D. Tarantino et al.
2292 Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions Jennifer Series et al.
Hemostasis
2300 Dynamic prediction of bleeding risk in thrombocytopenic preterm neonates Susanna F. Fustolo-Gunnink et al.
Coagulation & its Disorders
2307 Christmas disease in a Hovawart family resembling human hemophilia B Leyden is caused by a single nucleotide deletion in a highly conserved transcription factor binding site of the F9 gene promoter
Bertram Brenig et al.
Letters to the Editor
Letters are available online only at www.haematologica.org/content/104/11.toc
e494 Clinical and morphological predictors of outcome in older aplastic anemia patients treated with eltrombopag Bruno Fattizzo et al.
http://www.haematologica.org/content/104/11/e494
e497 Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas- and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells
Petros Patsali et al.
http://www.haematologica.org/content/104/11/e497
Stem Cell Transplantation
2314 Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation Pietro Merli et al.
haematologica Journal of the Ferrata Storti Foundation
Haematologica 2019; vol. 104 no. 11 - November 2019 http://www.haematologica.org/